Rockwell Medical (RMTI) Price to Sales (2010 - 2026)

Rockwell Medical (RMTI) has reported Price to Sales for 17 consecutive years, with 0.12 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 32.53% year-over-year to 0.12; the trailing twelve-month figure through Jun 2026 stood at 0.03 (down 5.37% YoY), and the FY2025 full-year result was 0.05, down 31.02% from the prior year.
• Price to Sales retreated to 0.12 in Q2 2026 per RMTI's latest filing, from 0.2 in the prior quarter.
• Across five years, Price to Sales topped out at 0.51 in Q2 2023 and bottomed at 0.05 in Q4 2022.
• Historically, Price to Sales has averaged 0.22 across 5 years, with a median of 0.2 in 2025.
• The sharpest annual moves came in 2022 and 2023: Price to Sales plunged 88.48% in 2022, then soared 680.84% in 2023.
• Over 5 years, Price to Sales stood at 0.05 in 2022, then jumped by 286.67% to 0.2 in 2023, then surged by 41.18% to 0.28 in 2024, then sank by 36.71% to 0.18 in 2025, then sank by 31.08% to 0.12 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 0.12, 0.2, and 0.18 for Q2 2026, Q1 2026, and Q4 2025 respectively.